David W Reid

Summary

Affiliation: University of Tasmania
Country: Australia

Publications

  1. ncbi Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease
    Sukhwinder S Sohal
    NHMRC National Centre for Research Excellence in Chronic Respiratory Disease, Menzies Research Institute, 17 Liverpool Street, Hobart, 7000, Australia
    Respir Res 12:130. 2011
  2. ncbi Tolerance and rebound with zafirlukast in patients with persistent asthma
    David W Reid
    Respiratory Research Group, Menzies Research Institute, University of Tasmania Hobart, Tasmania, Australia
    J Negat Results Biomed 7:3. 2008
  3. ncbi "Bong lung" in cystic fibrosis: a case report
    Zoe Gao
    Departments of Respiratory Medicine, Royal Hobart Hospital, Liverpool Street, Hobart, Tasmania, 7000, Australia
    J Med Case Reports 4:371. 2010
  4. ncbi Iron, Pseudomonas aeruginosa and cystic fibrosis
    D W Reid
    Discipline of Medicine, University of Tasmania Clinical School, 43 Collins Street, Hobart, Tasmania, 7000, Australia
    Microbiology 150:516; discussion 516-8. 2004
  5. ncbi Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
    D W Reid
    Cardiorespiratory Research Group, School of Medicine, University of Tasmania, Hobart, Australia
    Eur Respir J 30:286-92. 2007
  6. ncbi Atypical presentation of acute pancreatitis in a man with pancreatic insufficiency and cystic fibrosis: a case report
    Malcolm Turner
    Department of Respiratory Medicine, Royal Hobart Hospital, Tasmania, Australia
    J Med Case Reports 4:275. 2010
  7. ncbi Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis
    David W Reid
    Cardio Respiratory Research Group, University of Tasmania Medical School, Hobart, Tasmania, Australia
    Respirology 12:63-9. 2007
  8. ncbi Role of lung iron in determining the bacterial and host struggle in cystic fibrosis
    D W Reid
    Menzies Research Institute, Hobart, Tasmania
    Am J Physiol Lung Cell Mol Physiol 297:L795-802. 2009
  9. ncbi Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related
    David W Reid
    Respiratory Research Group, Menzies Research Institute, University of Tasmania, Hobart, Tasmania, Australia
    Respirology 13:799-809. 2008
  10. ncbi Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD
    Yudong Wen
    Menzies Research Institute, University of Tasmania, Hobart, Tasmania, Australia
    Int J Chron Obstruct Pulmon Dis 5:327-34. 2010

Collaborators

Detail Information

Publications36

  1. ncbi Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease
    Sukhwinder S Sohal
    NHMRC National Centre for Research Excellence in Chronic Respiratory Disease, Menzies Research Institute, 17 Liverpool Street, Hobart, 7000, Australia
    Respir Res 12:130. 2011
    ..Such changes are likely hallmarks of epithelial mesenchymal transition (EMT). We aimed to confirm the epithelial origin of these Rbm cells, and to exclude potential confounding by infiltrating inflammatory cells...
  2. ncbi Tolerance and rebound with zafirlukast in patients with persistent asthma
    David W Reid
    Respiratory Research Group, Menzies Research Institute, University of Tasmania Hobart, Tasmania, Australia
    J Negat Results Biomed 7:3. 2008
    ..The potential for tolerance to develop to zafirlukast, a cysteinyl leukotriene (CysLT) receptor antagonist (LRA) in persistent asthma, has not been specifically examined...
  3. ncbi "Bong lung" in cystic fibrosis: a case report
    Zoe Gao
    Departments of Respiratory Medicine, Royal Hobart Hospital, Liverpool Street, Hobart, Tasmania, 7000, Australia
    J Med Case Reports 4:371. 2010
    ..The underlying mechanism for bullae formation is uncertain, but probably relates to direct lung toxicity and repeated barotrauma as the smoker performs frequent valsalva manoeuvres in an attempt to derive a greater drug effect...
  4. ncbi Iron, Pseudomonas aeruginosa and cystic fibrosis
    D W Reid
    Discipline of Medicine, University of Tasmania Clinical School, 43 Collins Street, Hobart, Tasmania, 7000, Australia
    Microbiology 150:516; discussion 516-8. 2004
  5. ncbi Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
    D W Reid
    Cardiorespiratory Research Group, School of Medicine, University of Tasmania, Hobart, Australia
    Eur Respir J 30:286-92. 2007
    ..aeruginosa during an exacerbation. In conclusion, the present study suggests that increased airway iron may be important to Pseudomonas aeruginosa persistence in cystic fibrosis...
  6. ncbi Atypical presentation of acute pancreatitis in a man with pancreatic insufficiency and cystic fibrosis: a case report
    Malcolm Turner
    Department of Respiratory Medicine, Royal Hobart Hospital, Tasmania, Australia
    J Med Case Reports 4:275. 2010
    ..Whether acute pancreatitis can occur in pancreatically insufficient individuals with cystic fibrosis remains a matter of debate...
  7. ncbi Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis
    David W Reid
    Cardio Respiratory Research Group, University of Tasmania Medical School, Hobart, Tasmania, Australia
    Respirology 12:63-9. 2007
    ....
  8. ncbi Role of lung iron in determining the bacterial and host struggle in cystic fibrosis
    D W Reid
    Menzies Research Institute, Hobart, Tasmania
    Am J Physiol Lung Cell Mol Physiol 297:L795-802. 2009
    ....
  9. ncbi Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related
    David W Reid
    Respiratory Research Group, Menzies Research Institute, University of Tasmania, Hobart, Tasmania, Australia
    Respirology 13:799-809. 2008
    ..In particular, it is not known whether BDR is associated with underlying airway eosinophilia and whether BDR is predictive of a better response to inhaled corticosteroid (ICS) treatment...
  10. ncbi Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD
    Yudong Wen
    Menzies Research Institute, University of Tasmania, Hobart, Tasmania, Australia
    Int J Chron Obstruct Pulmon Dis 5:327-34. 2010
    ....
  11. ncbi Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions
    Che Y O'May
    Menzies Research Institute, University of Tasmania Clinical School, Hobart, Tasmania 7001, Australia
    J Med Microbiol 58:765-73. 2009
    ....
  12. ncbi Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study
    Amir Soltani
    Respiratory Research Group, Menzies Research Institute, University of Tasmania, 17 Liverpool St, Hobart, 7000, Australia
    Respir Res 11:105. 2010
    ..We conducted an initial pilot study comparing BB from COPD patients with nonsmoking controls. This pilot study suggested the presence of reticular basement membrane (Rbm) fragmentation and altered vessel distribution in COPD...
  13. ncbi Bronchial hyperresponsiveness and the bronchiolitis obliterans syndrome after lung transplantation
    David W Reid
    Lung Transplant Service, Department of Respiratory Medicine, The Alfred Hospital and Monash University, Melbourne, Australia
    J Heart Lung Transplant 24:489-92. 2005
    ....
  14. ncbi Bacterial cyanogenesis occurs in the cystic fibrosis lung
    K Sanderson
    Respiratory Research Group, Menzies Research Institute, University of Tasmania, Hobart, Australia
    Eur Respir J 32:329-33. 2008
    ..Cyanide is likely to be a potentially important virulence factor in Pseudomonas aeruginosa-infected cystic fibrosis patients...
  15. ncbi Population-based study of cystic fibrosis disease severity and haemochromatosis gene mutations
    Upasna Pratap
    Respiratory Research Group, Menzies Research Institute, University of Tasmania, Hobart, Tasmania 7001, Australia
    Respirology 15:141-9. 2010
    ..Haemochromatosis (HFE) mutations increase the risk of bowel obstruction in cystic fibrosis (CF), but the impact on other disease manifestations is unknown...
  16. ncbi Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population
    RICHARD BRADBURY
    Respiratory Research Group, Menzies Research Institute, University of Tasmania, Collins Street, Hobart, Tasmania, Australia
    Respirology 13:886-92. 2008
    ..Patients in Tasmania are geographically dispersed and when this study was conducted (2003) there was no central CF clinic, with patients receiving treatment in regional hospitals...
  17. ncbi Biofilm differentiation and dispersal in mucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    Sylvia M Kirov
    School of Medicine, University of Tasmania Clinical School, 43 Collins St, Hobart, Tasmania 7001, Australia
    Microbiology 153:3264-74. 2007
    ..aeruginosa in the CF airway...
  18. ncbi Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    David W Reid
    School of Medicine, University of Tasmania, Hobart, Tasmania, Australia
    FEMS Immunol Med Microbiol 48:373-80. 2006
    ..aeruginosa isolates tested. In vitro models used to research CF isolate biofilm growth need to take the above properties of these strains into account...
  19. ncbi Distinctive characteristics of bronchial reticular basement membrane and vessel remodelling in chronic obstructive pulmonary disease (COPD) and in asthma: they are not the same disease
    Amir Soltani
    Respiratory Research Group Descipline of Pathology, Menzies Research Institute, University of Tasmania, Hobart Queensland Institute of Medical Research, Brisbane Mercy Healthcare Victoria, Victoria, Australia
    Histopathology 60:964-70. 2012
    ..05] was also increased in COPD compared to normal subjects and asthmatics. Conclusions:? The characteristics of Rbm remodelling are quite different in asthma and COPD...
  20. ncbi Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection
    David W Reid
    Cystic Fibrosis Service, Department of Respiratory Medicine, Monash University Medical School, Alfred Hospital, Prahran, Melbourne, Vic, Australia
    Chest 121:48-54. 2002
    ....
  21. ncbi Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD
    Sushil Pant
    Cardio Respiratory Research Group, Menzies Research Institute, University of Tasmania, Australia
    Respirology 14:495-503. 2009
    ..An observational study was performed to determine how rapidly conventional treatment improves airway inflammation in patients admitted to hospital with AECOPD...
  22. ncbi Virulence gene distribution in clinical, nosocomial and environmental isolates of Pseudomonas aeruginosa
    R S Bradbury
    Microbiology Department, Royal Hobart Hospital, Liverpool Street, Hobart, TAS, Australia
    J Med Microbiol 59:881-90. 2010
    ..01) when compared to other clinical isolates (P<0.01), which may indicate decreased virulence. No specific virulence factor genotype was associated with the cystic fibrosis epidemic strains tested...
  23. ncbi Airway cell and cytokine changes in early asthma deterioration after inhaled corticosteroid reduction
    Y H Khor
    Respiratory Research Group, Menzies Research Institute, University of Tasmania, Hobart, Tasmania, Australia
    Clin Exp Allergy 37:1189-98. 2007
    ..We aimed at assessing the underlying pathological changes in relation to clinical deterioration...
  24. ncbi Epidemiology of Pseudomonas aeruginosa in a tertiary referral teaching hospital
    R S Bradbury
    Microbiology Department, Royal Hobart Hospital, Cardio Respiratory Research Group, Menzies Research Institute, School of Medicine, University of Tasmania, Hobart, Tasmania
    J Hosp Infect 73:151-6. 2009
    ..P. aeruginosa in the non-CF settings was found to be panmictic, and no cross-infection or acquisition of hospital environment strains by patients was observed...
  25. ncbi Antimicrobial susceptibility testing of cystic fibrosis and non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa: a comparison of three methods
    R S Bradbury
    CF Research Group, Menzies Research Institute, School of Medicine, University of Tasmania, Hobart, Australia
    Br J Biomed Sci 68:1-4. 2011
    ..aeruginosa infection...
  26. ncbi Airway distensibility in normal and asthmatic subjects and partitioning of the Fowler dead space
    David P Johns
    Cardio Respiratory Research Group, School of Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia
    Appl Physiol Nutr Metab 31:460-6. 2006
    ..005). We conclude that in both asthmatic and healthy subjects, the major component of DeltaVDF was DeltaVDp1 and not DeltaVDp2, as originally hypothesized. We believe our results are reflecting the degree of asynchronous airway emptying...
  27. ncbi BAL eotaxin and IL-5 in asthma, and the effects of inhaled corticosteroid and beta2 agonist
    Bryce N Feltis
    Respiratory Research Group, Tasmanian School of Medicine, University of Tasmania, Hobart, Tasmania, Australia
    Respirology 9:507-13. 2004
    ..It is hypothesised that changes in airway eosinophils would be related to eosinophil cytokines...
  28. ncbi Increased vascular permeability precedes cellular inflammation as asthma control deteriorates
    Y H Khor
    Respiratory Research Group, Menzies Research Institute, University of Tasmania, Hobart, Tasmania, Australia
    Clin Exp Allergy 39:1659-67. 2009
    ..We prospectively assessed the vascular changes accompanying worsening of asthma control by using an inhaled corticosteroid (ICS) dose-reduction model...
  29. ncbi Biosignificance of bacterial cyanogenesis in the CF lung
    R D Anderson
    School of Medicine, University of Tasmania, Hobart, Tasmania, 7001, Australia
    J Cyst Fibros 9:158-64. 2010
    ..This review discusses the implications of cyanogenesis in the CF airway in terms of bacterial ecology, host immune response, progression of lung disease and potential treatment options...
  30. ncbi Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling
    E H Walters
    Cardio Respiratory Research Group, Menzies Research Institute, University of Tasmania, 43 Collins Street, Hobart 7001, Australia
    Eur Respir J 30:574-88. 2007
    ..The areas where it is believed urgent research needs to be focused have also been highlighted...
  31. ncbi Decreased lung capillary blood volume post-exercise is compensated by increased membrane diffusing capacity
    D P Johns
    Discipline of Medicine, School of Medicine, University of Tasmania, 7001 Hobart, Tasmania, Australia
    Eur J Appl Physiol 93:96-101. 2004
    ..It is suggested that this effect is brought about by the reorientation of red blood cells within the pulmonary capillaries following exercise...
  32. ncbi Reduced airway distensibility, fixed airflow limitation, and airway wall remodeling in asthma
    C Ward
    Department of Respiratory Medicine, Alfred Hospital and Monash University Medical School, Melbourne, Australia
    Am J Respir Crit Care Med 164:1718-21. 2001
    ..Our findings support the hypothesis that DeltaVD is a physiologic test that is reflective of airway remodeling...
  33. ncbi Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma
    B N Feltis
    Tasmanian School of Medicine, 43 Collins St, Hobart, Tasmania, Australia 7001
    Thorax 62:314-9. 2007
    ..A study was undertaken to explore angiogenic modulation by ICS and its likely regulation via vascular endothelial growth factor (VEGF), its receptors and the angiopoietins...
  34. ncbi Exhaled nitric oxide continues to reflect airway hyperresponsiveness and disease activity in inhaled corticosteroid-treated adult asthmatic patients
    David W Reid
    Department of Respiratory Medicine and Monash University Medical School, Alfred Hospital, Melbourne, Victoria, Australia
    Respirology 8:479-86. 2003
    ..However, whether eNO levels reflect disease activity in symptomatic asthmatics receiving moderate doses of inhaled corticosteroid (ICS) is more uncertain...
  35. ncbi Cystic fibrosis: ironing out the problem of infection?
    David W Reid
    Am J Physiol Lung Cell Mol Physiol 295:L23-4. 2008
  36. ncbi Bronchodilator reversibility testing: laboratory practices in Australia and New Zealand
    Brigitte M Borg
    Department of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital and Monash University Medical School, Melbourne, Vic
    Med J Aust 180:610-3. 2004
    ..This may have a significant effect on the diagnosis and management of patients. Laboratories should report the method used to assess bronchodilator response...